Topics

Articles

Product commercialization in Canada is by no means simple, but the end result presents its advantages

What Pharma Companies Need to Know About Entering the Great White North

Decision-making technologies come to the forefront of the AI space

Decisive Moves on the Digital Supply Chain

How pharma can speed up the journey with direct-to-patient models


Telehealth: Connecting the Dots

Pharma Commerce's podcasts offer new angles on its roster of key topics

Easy Listening

Urmi Prasad Richardson is President EMEA region, Thermo Fisher Scientific.

Given the biopharma sector‘s complex set of networks and supply chains, so it is not straightforward to shift towards net zero across all operations.

Environmental Sustainability: An Imperative for the Life Sciences Sector

Michael Wong is an Emeritus Board Member of the Harvard Business School Healthcare Alumni Association.

Dr. Frank Doyle, Dean of the Paulson School of Engineering and Applied Sciences at Harvard University, outlines his recommendations for Fortune 500 c-suites as they strive to attract, develop, and retain the best talent for their upcoming 2023 strategic plans.

A Harvard Dean’s Blueprint for Fortune 500 C-Suites to Magnify Their Growth Opportunities

A reflection on the industry's effort to foster and facilitate sustainability

Food for Thought from France 

EVERSANA CEO Jim Lang discusses the organization’s continuing rise in an industry that has seen seismic changes taking place

‘We’re Just Getting Started’—A Catch-Up with Jim Lang, CEO, EVERSANA

PC's new editor-in-chief details his thought process on familiarizing himself with a different side of the industry

Diving in Headfirst

It's time to include hubs in the patient treatment journey

Opinion